A Carmo1, J G Cunha-Vaz, A P Carvalho, M C Lopes. 1. Center of Ophthalmology, Institute for Biomedical Research on Light and Image, University of Coimbra, Portugal.
Abstract
BACKGROUND: Our previous results showed that in retinas from streptozotocin (STZ)-induced diabetic rats there is an increased level of interleukin-1beta (IL-1beta). This cytokine may be involved in the expression of the inducible isoform of the nitric oxide synthase (iNOS), with consequent synthesis of large amounts of NO and blood-retinal barrier (BRB) breakdown. AIMS: The aim of this work was to examine whether the administration of cyclosporin-A (Cs-A) to STZ-induced diabetic rats inhibits the synthesis of IL-1beta and the expression of the inducible proteins, iNOS and cyclo-oxygenase-2 (COX-2) in retinal cells, and whether the activity of these proteins contribute to BRB breakdown. METHODS: The level of IL-1beta was evaluated by ELISA and the NO production by L-[3H]-citrulline formation. Expression of iNOS and COX-2 proteins was determined by two methods, western blot and immunohistochemistry. The permeability of the BRB was assessed by quantification of the vitreous protein. RESULTS AND DISCUSSION: Our results indicated that the levels of IL-1beta and NO in retinas from Cs-A-treated diabetic rats are significantly reduced, as compared to that in non-treated diabetic rats. The treatment of diabetic rats with Cs-A also significantly inhibited the expression of the inducible proteins, iNOS and COX-2. The evaluation of the vitreous protein content revealed that Cs-A also reduces the BRB permeability. Taken together, these results suggest that the increased production of the inflammatory mediators, IL-1beta and NO, in diabetes may affect the BRB permeability and therefore contribute to the development of diabetic retinopathy.
BACKGROUND: Our previous results showed that in retinas from streptozotocin (STZ)-induced diabeticrats there is an increased level of interleukin-1beta (IL-1beta). This cytokine may be involved in the expression of the inducible isoform of the nitric oxide synthase (iNOS), with consequent synthesis of large amounts of NO and blood-retinal barrier (BRB) breakdown. AIMS: The aim of this work was to examine whether the administration of cyclosporin-A (Cs-A) to STZ-induced diabeticrats inhibits the synthesis of IL-1beta and the expression of the inducible proteins, iNOS and cyclo-oxygenase-2 (COX-2) in retinal cells, and whether the activity of these proteins contribute to BRB breakdown. METHODS: The level of IL-1beta was evaluated by ELISA and the NO production by L-[3H]-citrulline formation. Expression of iNOS and COX-2 proteins was determined by two methods, western blot and immunohistochemistry. The permeability of the BRB was assessed by quantification of the vitreous protein. RESULTS AND DISCUSSION: Our results indicated that the levels of IL-1beta and NO in retinas from Cs-A-treated diabeticrats are significantly reduced, as compared to that in non-treated diabeticrats. The treatment of diabeticrats with Cs-A also significantly inhibited the expression of the inducible proteins, iNOS and COX-2. The evaluation of the vitreous protein content revealed that Cs-A also reduces the BRB permeability. Taken together, these results suggest that the increased production of the inflammatory mediators, IL-1beta and NO, in diabetes may affect the BRB permeability and therefore contribute to the development of diabetic retinopathy.
Authors: Vidhya R Rao; Elizabeth Prescott; Namdev B Shelke; Ruchit Trivedi; Peter Thomas; Craig Struble; Tom Gadek; Charles A O'Neill; Uday B Kompella Journal: Invest Ophthalmol Vis Sci Date: 2010-05-05 Impact factor: 4.799
Authors: Aniruddha C Amrite; Surya P Ayalasomayajula; Narayan P S Cheruvu; Uday B Kompella Journal: Invest Ophthalmol Vis Sci Date: 2006-03 Impact factor: 4.799
Authors: Célia A Aveleira; Cheng-Mao Lin; Steven F Abcouwer; António F Ambrósio; David A Antonetti Journal: Diabetes Date: 2010-08-06 Impact factor: 9.461
Authors: Maria H Madeira; Raquel Boia; Paulo F Santos; António F Ambrósio; Ana R Santiago Journal: Mediators Inflamm Date: 2015-03-22 Impact factor: 4.711
Authors: Ghulam Mohammad; Mohammad Mairaj Siddiquei; Mohammad Imtiaz Nawaz; Ahmed M Abu El-Asrar Journal: J Diabetes Res Date: 2013-04-10 Impact factor: 4.011